We are live on
!
Find out more
BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
hedge funds and large institutions have $1.12M invested in Biodexa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
48% less capital invested
Capital invested by funds: $2.18M → $1.12M (-$1.06M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$81K |
| 2 |
SG
StoneX Group
New York
|
-$68K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$54K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$47K |
| 5 |
VF
Virtu Financial
New York
|
-$35K |